Envveno Medical Corp (NVNO) — 10-Q Filings
All 10-Q filings from Envveno Medical Corp. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (5)
-
enVVeno Medical Posts Zero Revenue, Deepens Losses in Q2
— Jul 31, 2025 Risk: high
enVVeno Medical Corp reported no revenue for the three and six months ended June 30, 2025, consistent with the prior year periods. The company's net loss for th -
enVVeno Medical Corp. Files Q1 2025 10-Q
— Apr 30, 2025 Risk: medium
enVVeno Medical Corp. filed its quarterly report for the period ending March 31, 2025. The company, formerly known as Hancock Jaffe Laboratories, Inc., is based -
enVVeno Medical Corp. Files Q3 2024 10-Q
— Oct 31, 2024 Risk: medium
enVVeno Medical Corp. filed its 10-Q for the period ending September 30, 2024. The company, formerly known as Hancock Jaffe Laboratories, Inc., is focused on su -
enVVeno Medical Corp. Files Q2 2024 10-Q
— Jul 31, 2024 Risk: medium
enVVeno Medical Corp. filed its 10-Q for the period ending June 30, 2024. The company, formerly known as Hancock Jaffe Laboratories, Inc., reported financial re -
enVVeno Medical Corp Files 10-Q for Q1 2024
— May 8, 2024 Risk: low
enVVeno Medical Corp (NVNO) filed a Quarterly Report (10-Q) with the SEC on May 8, 2024. Filing is a 10-Q for the quarterly period ended March 31, 2024. Company
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX